Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial

COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech (SVA.O) to target the Omicron variant were approved for clinical trials in Hong Kong, the companies said on Saturday. Scientists worldwide are racing to ..

North Korea rejects offer of nearly 3 million Sinovac COVID-19 shots

REUTERS North Korea has rejected roughly three million COVID-19 vaccine doses of China's Sinovac Biotech (SVA.O), saying they should be sent to severely affected countries, the UNICEF said o...

Higher risk of Bell's Palsy after Sinovac's COVID-19 vaccine - study

REUTERS Risk of Bell's Palsy, a type of facial paralysis, is higher after the first dose of Sinovac Biotech Ltd's (SVA.O) COVID-19 vaccine CoronaVac, according to a study published ...

Saudi Arabia allows entry of Sinopharm and Sinovac vaccinated people after Booster dose

Saudi Arabia has decided to allow entry to foreign travellers fully vaccinated with either Sinopharm or Sinovac vaccines, provided that they also receive a booster shot of either of the four vaccines approved by the Kingdom, according to the country&..

Antibodies from Sinovac's COVID-19 shot fade after about 6 months, booster helps - study

Antibodies triggered by Sinovac Biotech's (SVA.O) COVID-19 vaccine decline below a key threshold from around six months after a second dose for most recipients, although a third shot could have a strong boosting ...

Hundreds of Thai medical workers infected despite Sinovac vaccinations